The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multinational, randomized, phase III trial of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab as second-line therapy for metastatic colorectal cancer: Safety analysis of Asian XELIRI project (AXEPT).
 
Masato Nakamura
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
 
Tae Won Kim
Honoraria - Amgen; Lilly
Research Funding - Bayer (Inst)
 
Rui-hua Xu
No Relationships to Disclose
 
Young Suk Park
No Relationships to Disclose
 
Yong Sang Hong
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Takeshi Kato
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma; Yakult Honsha
Expert Testimony - Lilly
Travel, Accommodations, Expenses - Eisai
 
Sang Hee Cho
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Hiroshi Matsuoka
No Relationships to Disclose
 
Sae-Won Han
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Akitaka Makiyama
No Relationships to Disclose
 
Keun-Wook Lee
Research Funding - AstraZeneca (Inst); Green Cross (Inst); MSD (Inst)
 
Yi Ba
No Relationships to Disclose
 
Mitsuyoshi Ota
No Relationships to Disclose
 
Satoru Iwasa
Honoraria - Chugai Pharma; Lilly Japan; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Lilly Japan (Inst); Merck (Inst); Novartis (Inst)
 
Satoshi Morita
Honoraria - Chugai Pharma
 
Yasuhide Yamada
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Yakult Honsha
 
Kei Muro
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha